We serve Chemical Name:2-Chloro-3-methoxypyridin-4-ol CAS:1227600-20-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-Chloro-3-methoxypyridin-4-ol
CAS.NO:1227600-20-5
Synonyms:2-Chloro-3-methoxypyridin-4-ol
Molecular Formula:C6H6ClNO2
Molecular Weight:159.57000
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:42.35000
Exact Mass:159.00900
LogP:1.44920
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-Chloro-3-methoxypyridin-4-ol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Chloro-3-methoxypyridin-4-ol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Chloro-3-methoxypyridin-4-ol Use and application,2-Chloro-3-methoxypyridin-4-ol technical grade,usp/ep/jp grade.
Related News: AXON is planning a follow-up trial that will include a better-defined group of Alzheimer’s patients suffering from both amyloid plaques and tau tangles, Novak said. 2-Chloro-3-methoxypyridin-4-ol manufacturer In approving the first new Alzheimer’s drug in nearly 20 years, the U.S. Food and Drug Administration is taking its biggest risk yet with a strategy that allows new therapies onto the market without strong evidence that they work, regulatory and scientific experts say. 2-Chloro-3-methoxypyridin-4-ol supplier The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China��s public hospitals, where most Chinese people buy their drugs. 2-Chloro-3-methoxypyridin-4-ol vendor The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China��s public hospitals, where most Chinese people buy their drugs. 2-Chloro-3-methoxypyridin-4-ol factory AXON is planning a follow-up trial that will include a better-defined group of Alzheimer’s patients suffering from both amyloid plaques and tau tangles, Novak said.
